Journal of Antimicrobial Chemotherapy (1996) 37, 519-533
© 1996 The British Society for Antimicrobial Chemotherapy
research-article |
Comparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell line
L.P.B.C. (URA CNRS 2056), Universite Pierre et Marie Curie 4 Place Jussieu, 75252 Paris Cedex 05, France
Received 17 February 1995; returned 27 July 1995; accepted 31 October 1995
*Corresponding author
The amount of amphotericin B (AmB) associated with cultured murine macrophage-like J774 cells, after incubation with various AmB lipid formulations, was determined by absorption spectroscopy. Large, negatively charged, AmB-containing, multilamellar vesicles and small cholesteryl sulphate-AmB complexes both enhanced the amount of AmB associated with J774 cells at 37°C (up to 500-fold the extracellular concentration). In contrast, AmB-containing, small, negatively charged vesicles (AmBisome), positively charged, oligolamellar vesicles and mixed micelles showed a lower association of the antibiotic with cells, compared with AmB added from a solution in dimethylsulphoxide or Fungizone. Experiments performed at 4°C showed a large reduction of AmB uptake for AmB preparations and AmB added from a solution in dimethysulphoxide or Fungizone, suggesting a high percentage of internalization of the antibiotic. Experiments in the presence of cytochalasin B resulted in a decrease of AmB uptake mainly for the preparations of large diameter, suggesting that these formulations were taken up by phagocytosis. A comparative study with Chinese hamster ovary cells, a model of non-phagocytic cells, snowed a reduction in the take up of AmB. This reduction was always more marked when AmB was incorporated in lipid formulations. On the other hand, accumulation of the antibiotic in J774 cells was shown to be followed by its release from the cells in an unbound form, the extent of release depending on the type of vector used. The results suggest that in some cases macrophages can be considered as reservoirs of antibiotic, releasing free AmB in the medium.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Takemoto, Y. Yamamoto, Y. Ueda, Y. Sumita, K. Yoshida, and Y. Niki Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis J. Antimicrob. Chemother., April 1, 2006; 57(4): 724 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Razonable, M. Henault, L. N. Lee, C. Laethem, P. A. Johnston, H. L. Watson, and C. V. Paya Secretion of Proinflammatory Cytokines and Chemokines during Amphotericin B Exposure Is Mediated by Coactivation of Toll-Like Receptors 1 and 2 Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1617 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Maes, D. V. Berghe, N. Germonprez, L. Quirijnen, P. Cos, N. De Kimpe, and L. Van Puyvelde In Vitro and In Vivo Activities of a Triterpenoid Saponin Extract (PX-6518) from the Plant Maesa balansae against Visceral Leishmania Species Antimicrob. Agents Chemother., January 1, 2004; 48(1): 130 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cheron, C. Petit, J. Bolard, and F. Gaboriau Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774 J. Antimicrob. Chemother., December 1, 2003; 52(6): 904 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Espuelas, P. Legrand, M. A. Campanero, M. Appel, M. Cheron, C. Gamazo, G. Barratt, and J. M. Irache Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice J. Antimicrob. Chemother., September 1, 2003; 52(3): 419 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Larabi, P. Legrand, M. Appel, S. Gil, M. Lepoivre, J.-P. Devissaguet, F. Puisieux, and G. Barratt Reduction of NO Synthase Expression and Tumor Necrosis Factor Alpha Production in Macrophages by Amphotericin B Lipid Carriers Antimicrob. Agents Chemother., February 1, 2001; 45(2): 553 - 562. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kuhara, K. Uchida, and H. Yamaguchi Therapeutic Efficacy of Human Macrophage Colony-Stimulating Factor, Used Alone and in Combination with Antifungal Agents, in Mice with Systemic Candida albicans Infection Antimicrob. Agents Chemother., January 1, 2000; 44(1): 19 - 23. [Abstract] [Full Text]
|
|
|
|
|
|
E. W. M. van Etten, W. van Vianen, J. Hak, and I. A. J. M. Bakker-Woudenberg Activity of Liposomal Amphotericin B with Prolonged Circulation in Blood versus Those of AmBisome and Fungizone against Intracellular Candida albicans in Murine Peritoneal Macrophages Antimicrob. Agents Chemother., September 1, 1998; 42(9): 2437 - 2439. [Abstract] [Full Text]
|
|